國立虎尾科技大學 |

Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development = A Focus on Early Phase Clinical Studies /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development/ edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch.
其他題名:	A Focus on Early Phase Clinical Studies /
其他作者:	Krentz, Andrew J.
面頁冊數:	XII, 312 p. 76 illus., 39 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medicine. -
電子資源:	https://doi.org/10.1007/978-1-4471-4920-0
ISBN:	9781447149200

Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development = A Focus on Early Phase Clinical Studies /
Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug DevelopmentA Focus on Early Phase Clinical Studies /[electronic resource] :edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch. - 1st ed. 2015. - XII, 312 p. 76 illus., 39 illus. in color.online resource.

1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs.

This book aims to aid the selection of the most appropriate techniques for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, and related cardiometabolic disease. Clinical research methods for assessing the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycaemic clamp technique, have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. This book will aid the understanding of the need for new pharmacotherapies for type 1 diabetes, type 2 diabetes, and obesity and the molecular targets of drugs currently in development. Emerging technologies including the omics disciplines are considered together with practical and ethical issues of early phase clinical trials in subjects with cardiometabolic disorders. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.

ISBN: 9781447149200

Standard No.: 10.1007/978-1-4471-4920-0doiSubjects--Topical Terms:

644133
Medicine.

LC Class. No.: R1

Dewey Class. No.: 610

Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development = A Focus on Early Phase Clinical Studies /
LDR:03012nam a22003975i 4500 001 962431
003 DE-He213
005 20200630160951.0
007 cr nn 008mamaa
008 201211s2015 xxk| s |||| 0|eng d
020 $a 9781447149200 $9 978-1-4471-4920-0
024 7 $a 10.1007/978-1-4471-4920-0 $2 doi
035 $a 978-1-4471-4920-0
050 4 $a R1
072 7 $a MB $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MB $2 thema
082 0 4 $a 610 $2 23
245 1 0 $a Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development $h [electronic resource] : $b A Focus on Early Phase Clinical Studies / $c edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch.
250 $a 1st ed. 2015.
264 1 $a London : $b Springer London : $b Imprint: Springer, $c 2015.
300 $a XII, 312 p. 76 illus., 39 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs.
520 $a This book aims to aid the selection of the most appropriate techniques for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, and related cardiometabolic disease. Clinical research methods for assessing the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycaemic clamp technique, have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. This book will aid the understanding of the need for new pharmacotherapies for type 1 diabetes, type 2 diabetes, and obesity and the molecular targets of drugs currently in development. Emerging technologies including the omics disciplines are considered together with practical and ethical issues of early phase clinical trials in subjects with cardiometabolic disorders. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.
650 0 $a Medicine. $3 644133
650 0 $a Internal medicine. $3 644638
650 0 $a Diabetes. $3 582755
650 0 $a Metabolic diseases. $3 1253620
650 0 $a Pharmacology. $3 583819
650 0 $a Pharmaceutical technology. $3 557391
650 1 4 $a Medicine/Public Health, general. $3 668810
650 2 4 $a Internal Medicine. $3 668583
650 2 4 $a Metabolic Diseases. $3 593967
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
700 1 $a Krentz, Andrew J. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 973617
700 1 $a Heinemann, Lutz. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064469
700 1 $a Hompesch, Marcus. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064470
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9781447149217
776 0 8 $i Printed edition: $z 9781447149194
776 0 8 $i Printed edition: $z 9781447170327
856 4 0 $u https://doi.org/10.1007/978-1-4471-4920-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)